The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics

Journal of Cell Science

Volumn 126, Issue 22, 2013, Pages 5259-5270

  Johnson, Louise A ^a   Jackson, David G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Chemokine; DC trafficking; Endothelial; Endothelial cell; Inflammation; Lymphatic

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAM17 PROTEIN; CHEMOKINE RECEPTOR CCR7; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIX METALLOPROTEINASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; OXAZOLONE; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM DISEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN ALLERGY; UPREGULATION;

CHEMOKINE; DC TRAFFICKING; ENDOTHELIAL CELL; INFLAMMATION; LYMPHATIC;

ALLERGENS; ANIMALS; CHEMOKINE CCL21; CHEMOKINE CX3CL1; DENDRITIC CELLS; ENDOTHELIUM, LYMPHATIC; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MICE; RECEPTORS, CCR7; SKIN;

EID: 84888104893     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.135343     Document Type: Article

References (44)

1. Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M. and Jackson, D. G. (1999). LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789-801.
2. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A. and Schall, T. J. (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature 385, 640-644.
3. Bourd-Boittin, K., Basset, L., Bonnier, D., L'helgoualc'h, A., Samson, M. and Théret, N. (2009). CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver. J. Cell. Mol. Med. 13 8A, 1526-1535.
4. Dransfield, I., Cabañ as, C., Barrett, J. and Hogg, N. (1992). Interaction of leukocyte integrins with ligand is necessary but not sufficient for function. J. Cell Biol. 116, 1527-1535.
5. Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T. and Patel, D. D. (1998). Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188, 1413-1419.
6. Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E. and Lipp, M. (1999). CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33.
7. Garton, K. J., Gough, P. J., Blobel, C. P., Murphy, G., Greaves, D. R., Dempsey, P. J. and Raines, E. W. (2001). Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276, 37993-38001.
8. Garton, K. J., Gough, P. J. and Raines, E. W. (2006). Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J. Leukoc. Biol. 79, 1105-1116.
9. Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M. and Ley, K. (2010). Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661.
10. Goda, S., Imai, T., Yoshie, O., Yoneda, O., Inoue, H., Nagano, Y., Okazaki, T., Imai, H., Bloom, E. T., Domae, N. et al. (2000). CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and - independent mechanisms. J. Immunol. 164, 4313-4320.
11. Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T. and Nakano, H. (1999). Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189, 451-460.
12. Haskell, C. A., Cleary, M. D. and Charo, I. F. (1999). Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J. Biol. Chem. 274, 10053-10058.
13. Huang, Y. W., Su, P., Liu, G. Y., Crow, M. R., Chaukos, D., Yan, H. and Robinson, L. A. (2009). Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases. J. Biol. Chem. 284, 29644-29653.
14. Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V. et al. (2003). The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102, 1186-1195.
15. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J. et al. (1997). Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521-530.
16. Johnson, L. A. and Jackson, D. G. (2010). Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration. Int. Immunol. 22, 839-849.
17. Johnson, L. A., Clasper, S., Holt, A. P., Lalor, P. F., Baban, D. and Jackson, D. G. (2006). An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203, 2763-2777.
18. Johnson, L. A., Prevo, R., Clasper, S. and Jackson, D. G. (2007). Inflammationinduced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 282, 33671-33680.
19. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A. and Littman, D. R. (2000). Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106-4114.
20. Kabashima, K., Shiraishi, N., Sugita, K., Mori, T., Onoue, A., Kobayashi, M., Sakabe, J., Yoshiki, R., Tamamura, H., Fujii, N. et al. (2007). CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am. J. Pathol. 171, 1249-1257.
21. Kriehuber, E., Breiteneder-Geleff, S., Groeger, M., Soleiman, A., Schoppmann, S. F., Stingl, G., Kerjaschki, D. and Maurer, D. (2001). Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194, 797-808.
22. Lämmermann, T., Bader, B. L., Monkley, S. J., Worbs, T., Wedlich-Söldner, R., Hirsch, K., Keller, M., Förster, R., Critchley, D. R., Fässler, R. et al. (2008). Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453, 51-55.
23. Liu, G. Y., Kulasingam, V., Alexander, R. T., Touret, N., Fong, A. M., Patel, D. D. and Robinson, L. A. (2005). Recycling of the membrane-anchored chemokine, CX3CL1. J. Biol. Chem. 280, 19858-19866.
24. Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A. and Sallusto, F. (2003). Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198, 615-621.
25. Moatti, D., Faure, S., Fumeron, F., Amara, M.-W., Seknadji, P., McDermott, D. H., Debré, P., Aumont, M. C., Murphy, P. M., de Prost, D. et al. (2001). Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97, 1925-1928.
26. Muehlhoefer, A., Saubermann, L. J., Gu, X., Luedtke-Heckenkamp, K., Xavier, R., Blumberg, R. S., Podolsky, D. K., MacDermott, R. P. and Reinecker, H. C. (2000). Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J. Immunol. 164, 3368- 3376.
27. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T., Henning, G. and Förster, R. (2004). CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279-288.
28. Palframan, R. T., Jung, S., Cheng, G., Weninger, W., Luo, Y., Dorf, M., Littman, D. R., Rollins, B. J., Zweerink, H., Rot, A. et al. (2001). Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194, 1361-1374.
29. Pan, Y., Lloyd, C., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J. A., Vath, J., Gosselin, M., Ma, J., Dussault, B. et al. (1997). Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387, 611-617.
30. Patel, D. D., Koopmann, W., Imai, T., Whichard, L. P., Yoshie, O. and Krangel, M. S. (2001). Chemokines have diverse abilities to form solid phase gradients. Clin. Immunol. 99, 43-52.
31. Prevo, R., Banerji, S., Ferguson, D. J. P., Clasper, S. and Jackson, D. G. (2001). Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276, 19420-19430.
32. Qu, C., Edwards, E. W., Tacke, F., Angeli, V., Llodrá , J., Sanchez-Schmitz, G., Garin, A., Haque, N. S., Peters, W., van Rooijen, N. et al. (2004). Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 200, 1231-1241.
33. Rao, R. M., Yang, L., Garcia-Cardena, G. and Luscinskas, F. W. (2007). Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ. Res. 101, 234-247.
34. Saeki, H., Moore, A. M., Brown, M. J. and Hwang, S. T. (1999). Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162, 2472-2475.
35. Scheinecker, C., McHugh, R., Shevach, E. M. and Germain, R. N. (2002). Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079-1090.
36. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C. (2003). Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
37. Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N. et al. (2007). Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194.
38. Tal, O., Lim, H. Y., Gurevich, I., Milo, I., Shipony, Z., Ng, L. G., Angeli, V. and Shakhar, G. (2011). DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 208, 2141-2153.
39. Umehara, H., Goda, S., Imai, T., Nagano, Y., Minami, Y., Tanaka, Y., Okazaki, T., Bloom, E. T. and Domae, N. (2001). Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol. Cell Biol. 79, 298-302.
40. Viemann, D., Goebeler, M., Schmid, S., Klimmek, K., Sorg, C., Ludwig, S. and Roth, J. (2004). Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells. Blood 103, 3365-3373.
41. Weber, M., Hauschild, R., Schwarz, J., Moussion, C., de Vries, I., Legler, D. F., Luther, S. A., Bollenbach, T. and Sixt, M. (2013). Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339, 328-332.
42. White, G. E. and Greaves, D. R. (2012). Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators. Arterioscler. Thromb. Vasc. Biol. 32, 589-594.
43. Wolff, B., Burns, A. R., Middleton, J. and Rot, A. (1998). Endothelial cell ''memory'' of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J. Exp. Med. 188, 1757-1762.
44. Yoshikawa, M., Nakajima, T., Matsumoto, K., Okada, N., Tsukidate, T., Iida, M., Otori, N., Haruna, S., Moriyama, H., Imai, T. et al. (2004). TNF-alpha and IL-4 regulate expression of fractalkine (CX3CL1) as a membrane-anchored proadhesive protein and soluble chemotactic peptide on human fibroblasts. FEBS Lett. 561, 105-110.